Journal article
Osteopontin splice variant as a potential marker for metastatic disease in pancreatic adenocarcinoma
Journal of gastroenterology and hepatology, v 29(6), pp 1321-1327
Jun 2014
PMID: 24548099
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Background and AimOsteopontin (OPN) is a phosphoprotein that activates pathways that induce cancer cell survival and metastasis. Our aim was to examine the expression pattern of OPN splice variants a, b, and c in fine-needle aspirates and to determine their correlation with stage-adjusted pancreatic ductal adenocarcinoma (PDA) survival.
MethodsEndoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) was performed in patients with solid pancreatic masses. The tissue was collected and analyzed for the expression of OPN isoforms by reverse transcription-polymerase chain reaction. Survival curves of stages and overexpression of OPN splice variants (a, b, c) were estimated according to the Kaplan-Meier and the log-rank test.
ResultsEUS-FNA was performed in 46 patients with solid pancreatic lesions (40 PDA and 6 chronic pancreatitis). OPNa was highly expressed in 39/40 (98%), OPNb in 24/40 (60%), while OPNc was present in 10/40 (25%) of PDA samples. The median survival was lower in patients whose fine-needle aspiration (FNA) samples expressed OPNb than those without (406 days vs 749 days, P=0.049). There was no significant difference in survival in patients with OPNc. Cox proportional hazard model demonstrated that OPNb expression had a trend toward decrease overall survival (P=0.06), with these patients having a hazard of death three times higher than those without. OPNc was found to significantly correlate with metastatic disease (P=0.009) in PDA patients.
ConclusionsOur data show for the first time that in FNA samples, there is a strong association between OPNc and presence of metastasis in PDA, and OPNb and poor survival.
Metrics
Details
- Title
- Osteopontin splice variant as a potential marker for metastatic disease in pancreatic adenocarcinoma
- Creators
- Ali A. Siddiqui - Thomas Jefferson UniversityElizabeth Jones - Thomas Jefferson UniversityDarren Andrade - Thomas Jefferson UniversityApeksha Shah - Thomas Jefferson UniversityThomas E. Kowalski - Thomas Jefferson UniversityDavid E. Loren - Thomas Jefferson UniversityGalina Chipitsyna - Thomas Jefferson UniversityHwyda A. Arafat - Thomas Jefferson University
- Publication Details
- Journal of gastroenterology and hepatology, v 29(6), pp 1321-1327
- Publisher
- Wiley
- Number of pages
- 7
- Grant note
- 1R21 CA133753-02 / NIH; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA R21CA133753 / NATIONAL CANCER INSTITUTE; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI) Thomas Jefferson University Hospital
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- College of Medicine
- Web of Science ID
- WOS:000335973300031
- Scopus ID
- 2-s2.0-84900555692
- Other Identifier
- 991022047145404721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Web of Science research areas
- Gastroenterology & Hepatology